Leidos Holdings, Inc.

NYSE:LDOS Stok Raporu

Piyasa değeri: US$15.9b

Leidos Holdings Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Leidos Holdings kazanç ve gelirin sırasıyla yıllık 5.8% ve 5.3% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 8.3% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 25.7% olacağı tahmin edilmektedir.

Anahtar bilgiler

5.8%

Kazanç büyüme oranı

8.34%

EPS büyüme oranı

Professional Services kazanç büyümesi15.4%
Gelir büyüme oranı5.3%
Gelecekteki özkaynak getirisi25.68%
Analist kapsamı

Good

Son güncelleme20 May 2026

Gelecekteki son büyüme güncellemeleri

Recent updates

Seeking Alpha May 09

Look Past Leidos Holdings' Shrinking Share Price To Its High Return On Equity

Summary Leidos Holdings is rated Buy, with a 10.4% upside target based on strong fundamentals and a widening gap between earnings and share price. LDOS's high return on equity (30.49%) and management's NorthStar 2030 strategy underpin expectations for continued growth and compounding returns. Recent price declines are attributed to macro factors like the U.S. government shutdown, not deterioration in LDOS's earnings or operational performance. Integration of ENTRUST and ongoing reliance on government contracts present risks, but improving fundamentals and guidance support a positive outlook. Read the full article on Seeking Alpha
Anlatı Güncellemesi May 02

LDOS: Defense Tech Contracts And AI Alliance Will Offset 2026 VBA Drag

The updated analyst price target for Leidos Holdings has been trimmed by about $5 to roughly $199 per share. Analysts factored in recent target cuts around mixed Q4 results, modestly lower revenue growth assumptions, a slightly higher discount rate, and a somewhat lower future P/E multiple, even as profit margin expectations edge up.
Anlatı Güncellemesi Apr 17

LDOS: Defense Tech And AI Partnership Will Offset 2026 VBA Headwinds

Leidos Holdings' updated analyst price target has moved lower by about $5 per share to reflect a slightly higher discount rate, a reduced future P/E assumption, and tempered margin expectations, as analysts factor in mixed Q4 results, recent target cuts from several firms, and ongoing headwinds in Veterans Benefits Administration work, even as growth initiatives continue. Analyst Commentary Recent research updates on Leidos point to a more cautious valuation framework, even as some analysts still see upside tied to growth investments and capital allocation changes.
Anlatı Güncellemesi Apr 03

LDOS: Defense Tech And AI Contracts Will Offset 2026 VBA Slowdown

Analysts have trimmed the average price target for Leidos Holdings to $209 from about $212, reflecting slightly higher discount rate assumptions, modestly adjusted growth and margin expectations, and mixed reactions to recent Q4 results and contract headwinds. Analyst Commentary Recent research paints a mixed picture around Leidos Holdings, with both optimistic and cautious views emerging after the latest Q4 report, updated guidance, and evolving contract exposure.
Anlatı Güncellemesi Mar 19

LDOS: Defense Tech And AI Expansion Will Offset 2026 VBA Contract Slowdown

Analysts have trimmed the blended price target on Leidos Holdings by about $1.50 to roughly $212.50, reflecting slightly softer long term growth and margin assumptions after mixed Q4 results and evolving views on the VBA headwind and defense tech opportunities. Analyst Commentary Street research on Leidos Holdings has shifted toward a more balanced view, with price targets generally nudged lower and ratings clustered around Buy, Outperform, Hold, and Neutral.
Anlatı Güncellemesi Mar 05

LDOS: Defense Tech And AI Shift Will Offset 2026 VBA Headwinds

Analysts have reduced their blended price target for Leidos Holdings by about $4 to roughly $214, reflecting recent Q4 updates, mixed views on growth in 2026, and ongoing debate around the impact of slower Veterans Benefits Administration work versus opportunities in defense tech and other growth segments. Analyst Commentary Street research on Leidos presents a split view, with several firms trimming price targets after Q4 while still highlighting long term growth opportunities in defense technology and other higher growth areas.
Anlatı Güncellemesi Feb 18

LDOS: Defense Tech And AI Shift Will Support Premium Multiple

The updated fair value estimate for Leidos Holdings edges down to about $218 per share from roughly $219, as analysts adjust price targets lower, citing mixed Q4 results, a slowdown in Veterans Benefits Administration activity, and tempered views on future valuation and guidance, even as the company increases its focus on higher growth markets. Analyst Commentary Recent Street research on Leidos points to a split view, with some analysts focusing on long term growth opportunities and others stressing execution risks and valuation constraints following the latest Q4 report and guidance.
Yeni Anlatı Feb 15

The Grid Modernizer: Leidos and the $2.4 Billion Bet on Sovereign AI and Energy

Leidos is entering its February 17, 2026, earnings call in a unique "valuation gap." While the stock is trading near $176 , our DCF analysis suggests an intrinsic floor of $227 , representing a 29% upside. The current market hesitation stems from "leverage shock" following the $2.4 billion acquisition of ENTRUST Solutions Group.
Anlatı Güncellemesi Feb 04

LDOS: Entrust Acquisition And AI Partnerships Will Support Premium Multiple

Analysts nudged their blended price target on Leidos Holdings slightly higher to about US$219.31, reflecting a modestly higher assumed future P/E multiple while balancing recent target moves tied to enthusiasm around the Entrust acquisition and caution over potential 2026 contract headwinds. Analyst Commentary Recent research on Leidos highlights a split view, with some analysts leaning into the potential of the Entrust acquisition and others more focused on contract concentration and 2026 risk.
Anlatı Güncellemesi Jan 21

LDOS: Health And Civil Strength And VA Contract Risk Will Shape Premium Multiple

Narrative Update: Leidos Holdings Analysts have trimmed their blended price target on Leidos Holdings by about $1 per share to $219, reflecting slightly more conservative assumptions on revenue growth, margins, and future P/E, after balancing recent target increases from firms citing strong execution and portfolio positioning with concerns around a key high margin contract and the timing of proving its sustainability. Analyst Commentary Recent research on Leidos highlights a mix of optimism around the core business and caution around a key contract that could affect medium term growth and valuation multiples.
Anlatı Güncellemesi Jan 07

LDOS: Health And Civil Strength And Pipeline Visibility Will Support Premium Multiple

Analysts have nudged their fair value estimate for Leidos Holdings higher to about $219.85 from roughly $218.08, citing stronger recent earnings, solid Health & Civil margins, a 1.3x book to bill, a US$69b near term pipeline, and a view that the company merits a premium P/E multiple within government services. Analyst Commentary Bullish Takeaways Bullish analysts see the recent earnings beat as support for a higher fair value, pointing to execution in Health & Civil margins as a key driver of profitability.
Anlatı Güncellemesi Dec 16

LDOS: Strong Health And Civil Margins Will Support Future Premium Multiple

Analysts have raised their price target on Leidos Holdings to approximately $218.08 per share from about $218.08. This reflects slightly stronger expectations for revenue growth and sustained margins, supported by robust book to bill trends, a sizable near term pipeline, and upside earnings performance with higher profitability guidance into 2025.
Anlatı Güncellemesi Dec 02

LDOS: Strong Health And Civil Margins Will Support Continued Margin Upside

Leidos Holdings saw its average analyst price target rise from $210 to $230 as analysts highlighted robust Health & Civil margins, a strong contract pipeline, and increased profitability guidance following recent earnings results. Analyst Commentary Recent analyst reports have highlighted several factors influencing sentiment around Leidos Holdings following the latest earnings results and guidance updates.
Anlatı Güncellemesi Nov 18

LDOS: Near-Term Contract Pipeline Will Drive Continued Margin Upside

Leidos Holdings' analyst price target has increased from $201.83 to $218.08 per share, as analysts cite strong margins in Health and Civil segments, a robust $69 billion pipeline, and raised profitability guidance as driving factors for the upward revision. Analyst Commentary Recent analyst reports have highlighted several factors that shape both the bullish and cautious outlooks for Leidos Holdings following its stronger-than-expected earnings performance and revised guidance.
Analiz Makalesi Nov 06

Leidos Holdings (NYSE:LDOS) Is Increasing Its Dividend To $0.43

Leidos Holdings, Inc. ( NYSE:LDOS ) will increase its dividend from last year's comparable payment on the 31st of...
Anlatı Güncellemesi Nov 02

LDOS: Federal Health And Security Spending Will Drive Steady Performance Ahead

Leidos Holdings saw its analyst price target rise from approximately $198.50 to $201.83. Analysts cited the company’s ongoing momentum in health services, robust margins, and its positioning to benefit from expanding federal funding priorities.
Anlatı Güncellemesi Oct 18

Government Funding And Digital Transformation Will Create Future Value

The average analyst price target for Leidos Holdings was raised by approximately $4 to $198.50. Analysts highlighted improving healthcare margins, stronger execution in health and defense services, and the company's positioning to benefit from recent government funding priorities.
Anlatı Güncellemesi Oct 04

Government Funding And Digital Transformation Will Create Future Value

The analyst price target for Leidos Holdings has been increased by approximately $2 to $194.71, as analysts cite ongoing strength in healthcare margins, opportunities in defense solutions, and improved business execution as key factors supporting the higher valuation. Analyst Commentary Recent Street research updates reflect a generally positive outlook on Leidos Holdings, with multiple analysts raising their price targets and upgrading the stock in response to improved business execution and strong performance in key sectors.
Anlatı Güncellemesi Sep 19

Government Funding And Digital Transformation Will Create Future Value

Upward analyst revisions for Leidos Holdings reflect confidence in its strategic investments in health and border security, strong healthcare margins, and effective leadership, resulting in a modest price target increase from $190.15 to $192.66. Analyst Commentary Bullish analysts highlight Leidos' strategic investments in veteran health, border security, and autonomous maritime, positioning the company to benefit from new government funding priorities.
Analiz Makalesi Sep 06

Here's Why Leidos Holdings (NYSE:LDOS) Can Manage Its Debt Responsibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Anlatı Güncellemesi Sep 04

Government Funding And Digital Transformation Will Create Future Value

Analysts maintain a positive outlook on Leidos Holdings due to strong execution in Health Services, favorable positioning for government funding priorities, increased management confidence, and a strategic pivot toward higher-margin growth sectors, resulting in an unchanged $186.69 price target. Analyst Commentary Continued strength and solid execution within Leidos' Health Services business, contributing to improved outlook and confidence.
Analiz Makalesi Jun 19

Does Leidos Holdings (NYSE:LDOS) Deserve A Spot On Your Watchlist?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Seeking Alpha Apr 15

Leidos: A Defense Company To Consider

Summary Leidos Holdings, Inc. operates in defense, IT security, data analytics, and healthcare, recently realigning into four segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems. Leidos has shown strong performance, boasting a 450% total return over the past decade, exceeding returns of the overall market. The company has been growing its dividend for a few years, but I think they could offer investors higher increases. Read the full article on Seeking Alpha
Seeking Alpha Feb 02

Leidos: Fears Are Overblown, Take Advantage Of Market Uncertainty

Summary Leidos' shares have dropped significantly due to policy uncertainties, presenting a buying opportunity given its strong backlog and free cash flow generation. The company's Q3 '24 results showed robust growth with a 44% EPS increase and a $40.6 billion backlog, signaling future revenue stability. Despite political risks, Leidos' valuation is attractive at 10.3x EV/EBITDA, with strong dividend and share buyback potential. I rate Leidos a 'strong buy' due to its discounted valuation, solid financial position, and growth prospects in Health & Civil and National Security segments. Read the full article on Seeking Alpha
Seeking Alpha Nov 22

Leidos: Not Enough Margin Of Safety Despite Creating Value In A Low Growth Sector

Summary LDOS has consistently created shareholder value through a mix of organic growth and acquisitions. Despite improving operating and capital efficiencies, LDOS's returns have not shown an improving trend, and its valuation currently does not provide enough margin of safety. LDOS is financially sound with a good reinvestment rate and cash flow. But I recommend waiting for a 15% price drop before buying. Read the full article on Seeking Alpha

Kazanç ve Gelir Büyüme Tahminleri

NYSE:LDOS - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/202820,0501,6461,7942,0338
12/31/202719,1351,5461,6401,88414
12/31/202618,2331,4281,4791,80314
4/3/202617,3291,4131,8591,993N/A
1/2/202617,1741,4481,6251,750N/A
10/3/202517,3321,4051,3381,506N/A
7/4/202517,0531,4021,2821,442N/A
4/4/202516,9321,3331,2261,380N/A
1/3/202516,6621,2541,2861,435N/A
9/27/202416,2771,1991,3041,445N/A
6/28/202416,0084361,4251,593N/A
3/29/202415,7143211,1911,376N/A
12/29/202315,4381999801,187N/A
9/29/202315,155147804986N/A
6/30/202314,842708761920N/A
3/31/202314,601672661801N/A
12/30/202214,396685863992N/A
9/30/202214,1906829681,077N/A
7/1/202214,065725807913N/A
4/1/202213,916723779885N/A
12/31/202113,7377539291,033N/A
10/1/202113,498776635769N/A
7/2/202113,257734656796N/A
4/2/202112,7237181,0361,201N/A
1/1/202112,2976281,1511,334N/A
10/2/202011,9996121,3811,555N/A
7/3/202011,5926101,1471,312N/A
4/3/202011,4065939411,076N/A
1/3/202011,094667N/A992N/A
9/27/201910,787674N/A927N/A
6/28/201910,527660N/A949N/A
3/29/201910,328668N/A1,034N/A
12/28/201810,194581N/A768N/A
9/28/201810,063507N/A828N/A
6/29/20189,991442N/A724N/A
3/30/201810,033396N/A619N/A
12/29/201710,170366N/A526N/A
9/29/201710,229311N/A483N/A
6/30/20179,594320N/A486N/A
3/31/20178,311263N/A392N/A
12/30/20167,043244N/A449N/A
9/30/20165,803341N/A365N/A
7/1/20165,237299N/A364N/A
4/1/20165,206295N/A443N/A
1/1/20165,140265N/A409N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: LDOS 'nin tahmini kazanç büyümesi (yıllık 5.8% ) tasarruf oranının ( 3.5% ) üzerindedir.

Kazançlar ve Piyasa: LDOS şirketinin kazançlarının (yıllık 5.8% ) US pazarından (yıllık 16.8% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: LDOS şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: LDOS şirketinin gelirinin (yıllık 5.3% ) US pazarından (yıllık 11.7% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: LDOS şirketinin gelirinin (yıllık 5.3% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: LDOS 'in Özsermaye Getirisi'nin 3 yıl içinde yüksek olması tahmin ediliyor ( 25.7 %)


Büyüyen şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/05/24 03:27
Gün Sonu Hisse Fiyatı2026/05/22 00:00
Kazançlar2026/04/03
Yıllık Kazançlar2026/01/02

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Leidos Holdings, Inc. 24 Bu analistlerden 14, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
John EadeArgus Research Company
Peter ArmentBaird
David StraussBarclays